Evidence map›Paper›PMID 12368329›Full record

ArticleJournal of virology2002

Envelope proteins containing single amino acid substitutions support a structural model of the receptor-binding domain of bovine leukemia virus surface protein.

Elizabeth R Johnston, Lorraine M Albritton, Kathryn Radke

Open access · greenAbstract read
In one paragraph

Article in Journal of virology, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
0.6field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Molecular Characterization of thePathogens (Basel, Switzerland) · 2021
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Elizabeth R JohnstonDepartment of Animal Science and Graduate Group in Biochemistry and Molecular Biology, University of California, Davis, California 95616, USA.
Lorraine M Albritton
Kathryn Radke
University of California, Davis · USUniversity of Tennessee Health Science Center · US

Funding

UC Davis MCB T32 Administrative Supplement to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) MentorshipT32GM007377 · NIGMS · UNIVERSITY OF CALIFORNIA DAVIS · PI CHEDIN, FREDERIC LOUIS · 1985 to 2023
$9.9M
MUTATIONAL AND PHYSICAL ANALYSIS OF THE MULV-E RECEPTORR01AI033410 · NIAID · UNIVERSITY OF TENNESSEE HEALTH SCI CTR · PI ALBRITTON, LORRAINE M. · 1993 to 2007
$1.5M
TARGET CELL SPECIFICITY OF BOVINE LEUKEMIA VIRUSR01CA046374 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI RADKE, KATHRYN · 1988 to 1995
–
CELLULAR REGULATION OF BOVINE LEUKEMIA VIRUS REPLICATIONR55CA046374 · NCI · UNIVERSITY OF CALIFORNIA DAVIS · PI RADKE, KATHRYN · 1991 to 1991
–
NCI NIH HHS CA-46374NIAID NIH HHS AI-33410NIAID NIH HHS R01 AI033410NIGMS NIH HHS GM-07377NIGMS NIH HHS T32 GM007377
6 · The paper itself

Abstract

Functional domains of the strikingly conserved envelope (Env) glycoproteins of bovine leukemia virus (BLV) and its close relative, human T-cell leukemia virus type 1 (HTLV-1), are still being defined. We have used BLV Env protein variants to gain insights into the structure and function of this important determinant of viral infectivity. Each of 23 different single amino acid variants found in cDNA clones of env transcripts present after short-term culture of peripheral blood mononuclear cells from BLV-infected sheep was expressed in COS-1 cells and tested for the ability to mediate cell fusion and to be cleaved to surface (SU) and transmembrane (TM) protein subunits. Of 11 Env variants that failed to induce syncytia or did so poorly, 7 contained changes in amino acids identical or chemically conserved in the HTLV-1 Env protein. These seven included the four variants that showed aberrant proteolytic cleavage and poor cell surface expression, underscoring their importance for Env structure. Ten of 12 variants that retained wild-type syncytium-inducing ability clustered in the N-terminal half of BLV SU, which forms the putative receptor-binding domain (RBD). Several variants in the RBD showed evidence of subtle misfolding, as judged by reduced binding to monoclonal antibodies recognizing conformational epitopes F, G, and H formed by the N terminus of SU. We modeled the BLV RBD by aligning putative structural elements with known elements of the ecotropic Friend murine leukemia virus RBD monomer. All the variant RBD residues but one are exposed on the surface of this BLV model. These variants as well as function-altering, antibody-reactive residues defined by other investigators group on one face of the molecular model. They are strikingly absent from the opposite face, implying that it is likely to face inward in Env complexes. This surface might interact with the C-terminal domain of SU or with an adjacent monomer in the Env oligomer. This location suggests an orientation for the monomer of ecotropic Friend murine leukemia virus RBD.

Indexed as

Amino Acid SequenceAmino Acid SubstitutionAnimalsBinding SitesCattleChlorocebus aethiopsCloning, MolecularCOS CellsGiant CellsHumansLeukemia Virus, BovineMolecular Sequence DataProtein Processing, Post-TranslationalReceptors, VirusSequence Homology, Amino AcidViral Envelope ProteinsReceptors, VirusViral Envelope Proteins

Identifiers

PMID12368329
PMCPMC136609
OpenAlexW2129856312

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.